Literature DB >> 1483308

Rheumatoid arthritis associated with high levels of immunoglobulin a: clinical and biological characteristics.

C Jorgensen1, J M Anaya, C Cognot, J Sany.   

Abstract

We measured the serum immunoglobulins in 191 patients with rheumatoid arthritis (RA) over an 8-month period, looking for a relationship between high IgA levels, disease activity, and clinical and biological features. Twenty-nine patients with a polyclonal hyperimmunoglobulin A (IgA) (15.2%) above 5 g/l constituted group A. A control group of 29 randomized RA patients with normal IgA levels was studied over the same period (group B). The mean serum IgA concentration was significantly elevated in group A: 6.6 +/- 1.8 g/l versus 2.8 +/- 0.9 g/l in group B (p < 0.01). In group A, microscopic haematuria occurred in 20.7% of the cases, as against 3.4% from group B (p < 0.05). Furthermore, the incidence of unilateral sacroiliitis and of arthritis of the distal interphalangeal joints was significantly increased in group A (41.4% and 34.5%, respectively) against 6.9% and 3.4% in group B (p < 0.01) and this correlated with a high IgA serum level (p < 0.01). On the other hand, neither disease activity nor the biological parameters of inflammation were influenced by the level of IgA. Patients with RA associated with high levels of IgA are characterized by a significant increase in the incidence of distal interphalangeal arthritis, unilateral sacroiliitis and microscopic haematuria. These clinical and biological features could define a distinct subgroup of patients with RA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483308

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Serum immunoglobulins and the risk of rheumatoid arthritis.

Authors:  K Aho; M Heliövaara; P Knekt; A Reunanen; A Aromaa; A Leino; P Kurki; R Heikkilä; T Palosuo
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  IgG1 deficiency and high IgA level with juvenile idiopathic arthritis.

Authors:  Bilal Yildiz; Nurdan Kural
Journal:  Eur J Pediatr       Date:  2006-11-29       Impact factor: 3.183

3.  Variation in the serum IgA concentration and the production of IgA in vitro in rheumatoid arthritis treated by sulfasalazine.

Authors:  C Jorgensen; C Bologna; J M Anaya; T Reme; J Sany
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

4.  Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis.

Authors:  Prathapan Ayyappan; Robert Z Harms; Jennifer A Seifert; Elizabeth A Bemis; Marie L Feser; Kevin D Deane; M Kristen Demoruelle; Ted R Mikuls; V Michael Holers; Nora E Sarvetnick
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.